Johnson & Johnson (JNJ)
145.05
-0.53
(-0.36%)
USD |
NYSE |
Dec 27, 16:00
145.15
+0.10
(+0.07%)
After-Hours: 20:00
Johnson & Johnson SG&A Expense (Quarterly): 5.278B for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly and Co | 2.100B |
| Merck & Co Inc | 2.731B |
| Pfizer Inc | 3.244B |
| AbbVie Inc | 4.205B |
| Bristol-Myers Squibb Co | 1.983B |